1. Home
  2. VTGN vs GECC Comparison

VTGN vs GECC Comparison

Compare VTGN & GECC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTGN
  • GECC
  • Stock Information
  • Founded
  • VTGN 1998
  • GECC 2016
  • Country
  • VTGN United States
  • GECC United States
  • Employees
  • VTGN N/A
  • GECC N/A
  • Industry
  • VTGN Biotechnology: Pharmaceutical Preparations
  • GECC Finance: Consumer Services
  • Sector
  • VTGN Health Care
  • GECC Finance
  • Exchange
  • VTGN Nasdaq
  • GECC Nasdaq
  • Market Cap
  • VTGN 99.6M
  • GECC 110.0M
  • IPO Year
  • VTGN N/A
  • GECC N/A
  • Fundamental
  • Price
  • VTGN $3.25
  • GECC $10.53
  • Analyst Decision
  • VTGN Strong Buy
  • GECC
  • Analyst Count
  • VTGN 2
  • GECC 0
  • Target Price
  • VTGN $13.50
  • GECC N/A
  • AVG Volume (30 Days)
  • VTGN 98.3K
  • GECC 15.7K
  • Earning Date
  • VTGN 08-13-2024
  • GECC 10-31-2024
  • Dividend Yield
  • VTGN N/A
  • GECC 13.29%
  • EPS Growth
  • VTGN N/A
  • GECC 25.36
  • EPS
  • VTGN N/A
  • GECC 1.22
  • Revenue
  • VTGN $971,000.00
  • GECC $36,895,000.00
  • Revenue This Year
  • VTGN N/A
  • GECC $15.88
  • Revenue Next Year
  • VTGN N/A
  • GECC $8.88
  • P/E Ratio
  • VTGN N/A
  • GECC $8.63
  • Revenue Growth
  • VTGN N/A
  • GECC 20.00
  • 52 Week Low
  • VTGN $2.45
  • GECC $8.38
  • 52 Week High
  • VTGN $7.10
  • GECC $11.82
  • Technical
  • Relative Strength Index (RSI)
  • VTGN 38.10
  • GECC 55.81
  • Support Level
  • VTGN $3.17
  • GECC $10.27
  • Resistance Level
  • VTGN $3.55
  • GECC $10.59
  • Average True Range (ATR)
  • VTGN 0.16
  • GECC 0.23
  • MACD
  • VTGN -0.03
  • GECC 0.05
  • Stochastic Oscillator
  • VTGN 12.90
  • GECC 88.89

About VTGN VistaGen Therapeutics Inc.

Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

About GECC Great Elm Capital Corp.

Great Elm Capital Corp is an externally managed, non-diversified closed-end management investment company. The company seeks to generate current income and capital appreciation through debt and equity investments, including investments in specialty finance businesses. It invests in senior secured and senior unsecured debt instruments, as well as in junior loans and mezzanine debt of middle-market companies and small businesses. The company generates revenue from interest on the debt investments that it holds.

Share on Social Networks: